281 related articles for article (PubMed ID: 11579012)
1. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
Einarson A; Fatoye B; Sarkar M; Lavigne SV; Brochu J; Chambers C; Mastroiacovo P; Addis A; Matsui D; Schuler L; Einarson TR; Koren G
Am J Psychiatry; 2001 Oct; 158(10):1728-30. PubMed ID: 11579012
[TBL] [Abstract][Full Text] [Related]
2. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
4. Use of antidepressants during pregnancy and the risk of spontaneous abortion.
Nakhai-Pour HR; Broy P; Bérard A
CMAJ; 2010 Jul; 182(10):1031-7. PubMed ID: 20513781
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
[TBL] [Abstract][Full Text] [Related]
6. Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Lennestål R; Källén B
J Clin Psychopharmacol; 2007 Dec; 27(6):607-13. PubMed ID: 18004128
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
Klieger-Grossmann C; Weitzner B; Panchaud A; Pistelli A; Einarson T; Koren G; Einarson A
J Clin Pharmacol; 2012 May; 52(5):766-70. PubMed ID: 22075232
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
[TBL] [Abstract][Full Text] [Related]
11. Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
Kjaersgaard MI; Parner ET; Vestergaard M; Sørensen MJ; Olsen J; Christensen J; Bech BH; Pedersen LH
PLoS One; 2013; 8(8):e72095. PubMed ID: 24015208
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
[TBL] [Abstract][Full Text] [Related]
13. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
de Moor RA; Mourad L; ter Haar J; Egberts AC
Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
[TBL] [Abstract][Full Text] [Related]
14. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
16. Cisapride use during human pregnancy: a prospective, controlled multicenter study.
Bailey B; Addis A; Lee A; Sanghvi K; Mastroiacovo P; Mazzone T; Bonati M; Paolini C; Garbis H; Val T; De Souza CF; Matsui D; Schechtman AS; Conover B; Lau M; Koren G
Dig Dis Sci; 1997 Sep; 42(9):1848-52. PubMed ID: 9331146
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants in pregnancy: a systematic review.
Udechuku A; Nguyen T; Hill R; Szego K
Aust N Z J Psychiatry; 2010 Nov; 44(11):978-96. PubMed ID: 21034181
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to antidepressants: how safe are they?
Steiner M
Am J Psychiatry; 2012 Nov; 169(11):1130-2. PubMed ID: 23128917
[No Abstract] [Full Text] [Related]
19. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
Kulin NA; Pastuszak A; Sage SR; Schick-Boschetto B; Spivey G; Feldkamp M; Ormond K; Matsui D; Stein-Schechman AK; Cook L; Brochu J; Rieder M; Koren G
JAMA; 1998 Feb; 279(8):609-10. PubMed ID: 9486756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]